Yaariv Khaykin: Can Some Patients Safely Stop Blood Thinners After AF Ablation?
Yaariv Khaykin, Associate Professor at Temerty Faculty of Medicine, University of Toronto, President and Physician Leader of Pace Cardiology, shared on LinkedIn about a recent article by Mohsin Raj Mantoo, published in Indian Pacing and Electrophysiology Journal, adding:
“One of the most common questions I get from patients after a successful AF ablation:
‘Can I stop my blood thinner?’
A new meta-analysis of over 242,000 patients (3 randomized trials with 7 observational studies) offers some of the strongest data we’ve had on this topic.
The findings:
- Stopping anticoagulation after the blanking period was not associated with increased thromboembolic events compared with continuing it (RR 0.93, 95% CI 0.86–1.02).
- Major bleeding was significantly lower in the discontinuation group (RR 0.38).
- Intracranial hemorrhage was reduced by roughly 77% (RR 0.23).
These numbers are striking — but I want to be careful here. Current guidelines still recommend basing anticoagulation on CHA2DS2-VASc score rather than rhythm status, and that’s appropriate given the limitations of observational data and the small randomized sample sizes.
What this analysis does, though, is strengthen the case for larger, properly powered randomized trials. For patients with low-to-moderate stroke risk who achieve durable sinus rhythm, the risk-benefit equation of lifelong anticoagulation deserves re-examination.
This is a conversation I have almost daily in clinic. The data are moving in a direction that may eventually give us more individualized answers — and that’s what patients are asking for.”
Title: Anticoagulation Discontinuation After Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis of Randomized and Observational Evidence
Authors: Mohsin Raj Mantoo, Saurav Suman, Mir Wajid Majeed, Somnath Mukherjee, Neeraj Parakh, Sharad Agarwal, Gautam Sharma, Ambuj Roy
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause